Live feed09:15:00·74dPRReleasevia QuantisnowBiofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary EndpointByQuantisnow·Wall Street's wire, on your screen.BFRI· Biofrontera Inc.Health CareOriginal source
